Panbela Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Panbela Therapeutics

12/08/2021 06:43

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted loss of 22 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Panbela Therapeutics Inc's reported EPS for the quarter was a
loss of 22 cents​.
* The mean earnings estimate of analysts had fallen by
about 17.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Panbela Therapeutics Inc shares had fallen by 15.2% this
quarter and lost 32.6% so far this year.
* The company reported a quarterly loss of $2.19 million.
* Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 05:42 a.m.  ​All
figures in US dollars unless otherwise stated